Agenda
Agenda
Download the Brochure
General Session
Monday, October 24 | |
7:00 | Breakfast |
8:00 |
Opening Remarks: Todd Eury, Pharmacy Podcast Network |
8:30
|
Panel: The Unlimited Opportunities of Entrepreneurial Practice of Pharmacy
|
9:15
|
Fireside Chat – Creating Protocols for Effective Treatment Of Disorders Effecting the Brain
|
10:00 |
RX Impact Idea: The power of Vision and Values for the Entrepreneur |
10:00 | Break – move into individual tracks |
Day 2: October 25 | |
7:00 | Breakfast |
8:00 | Recap of Day 1 |
8:00 | Opening Remarks, Recap of Day 1 |
8:15 |
RX Impact Idea – The Death of the Medical Cannabis Product, Jason S Nelson, COO, BeLeaf Medical |
9:15 |
Fireside chat: Proving Opiate Reduction Using Cannabis |
10:00 |
RX Impact Idea – Jena Quinn, PharmD, BCPPS, Owner, Perfecting Peds |
10:15 | Break – move into individual tracks |
Growth & Entrepreneurship
Tuesday, October 25 | |
12:30 | Special Event: Financial Planning for Women Pharmacists with Melissa Myers |
1:30 |
Panel: To B or not to B, that is the decade long question. 503A – B?
|
2:15 |
Activity: Your Dreams are URGENT! How to Move Forward in Life and Business
Are you stuck? Do you want to move forward in your life, become an entrepreneur, create new revenue streams for your business but find yourself unable to make any changes? Join Dr. Jerrica Dodd as she shares pearls and coaches on moving forward and building your dreams. |
3:15 | Break |
3:45 |
How do you grow without a team?
|
4:30 |
Round Tables: 1. Lean Six Sigma, Syed Saleem DPh, MBA, Senior Director, NexGen Pharmaceuticals 2. Team Building, Jena Quinn, PharmD, BCPPS, Owner, Perfecting Peds 3. Financial Planning, Melissa Myers, CFP ®, Wealth Manager-The Melissa Myers Group |
5:00 | End of Conference Day 1 |
Tuesday, October 25 | |
10:45 |
Niche Idea, New Ideas, Nuevo Pharma, or “How about this?
|
11:30 | Round Tables: |
|
|
12:30 | End Of Conference |
2:00 | Workshops begin |
Compounding
Monday, October 24 | |
10:45 |
Panel: Future of Compounding – Growth, Consolidation and New Opportunities
|
11:30 | Round Table Discussions (Visit 2 table topics during this hour) |
1. 503B Inspections
2. 503A Inspections
3. DEA Inspections
4. 503A Regulatory Update 5. 503B Regulatory Update |
|
12:30 | Special Event: Financial Planning for Women Pharmacists with Melissa Myers |
1:30
|
Panel: Preventing Process Deviations in A Fluctuating Workforce
|
2:15 | Round Tables (Visit 2 table topics during this hour) |
1. How to address opioid state fees
2. I’m Curious, How Do You Manage Workflow? Compare Systems from order Through Fulfillment 3. Conducting Your Own Environmental Monitoring
|
|
3:15 | Break |
3:45
|
Fireside chat: Essentially A Copy – A Challenge for Both 503As and 503Bs
|
4:30 | Round Tables |
1. Cited For What?! The Push For cGMP Like Rules and Standards in Sterile Facilities 2. Creating a culture of compliance and audit readiness
3. 503A Compliance
4. Animals are not people (???)
|
|
5:00 | End of Day 1 Conference |
Tuesday, October 25 | |
10:30
|
Panel: Retention and Hiring; Staff Development & Advancement
|
11:30 | Round Tables (Visit 2 table topics during this hour) |
1. Poaching and staff retention
2. Navigating the complexities of state licensing for 503Bs
3. 503B Compliance 4. Are you effectively moving technicians into leadership roles?
|
|
12:30 | End Of Conference |
2:00 | Workshops begin |
Cannabis
Monday, October 24 | |
10:45 |
Track Keynote – The History of Cannabis- Cannabis Introduction Topics
|
11:15 |
Panel: Discussion on Politics of Cannabis Treatment
|
12:00 | Round Tables: Learn more from the panelists, take a deeper dive and ask specific questions |
12:30 | Special Event: Financial Planning for Women Pharmacists with Melissa Myers |
1:30
|
Panel: Utilizing Cannabis as A Therapy for Chronic Pain Management
|
2:15 | Round Tables – (Visit 2 tables topics during this hour) |
1. Adverse Event Reporting
2. Building your auxiliary team
3. Different Q/A thresholds in different state markets
4. Routes of Administration and Cannabis and Cannabinoids Dosing |
|
3:15 | Break |
3:45
|
Regulatory Update: Hemp – 2018 US Farm Bill – Delta 8 THC, Delta 9 THC, Delta 10 THC
|
4:30 | Round Table |
1. Exploring the science – ask your questions here
2. Interstate Commerce Implications
3. Improving Patient Accessibility While Mitigating Black Market Appeal 4. How To Talk To A Doctor About Cannabis Usage |
|
5:00 | End of Conference Day 1 |
Tuesday, October 25 | |
10:45 |
Panel: Risks to Patients that Need to Be Considered
|
11:30 | Round Tables- (Visit 2 tables topics during this hour) |
1. Using Data from State Prescription Drug Management Program To Show Reduction On Opioid Use In Lieu Of Cannabis 2. Fair Market Value of Pain Cream 3. 4th Year Rx Student APPE Clinical Rotation
4. Improving patient relationships with practitioners
|
|
12:30 | End Of Conference |
2:00 | Workshops |
Pharmacogenomics
Monday, October 24 | |
10:45 | Panel: Reviewing clinical data Is utilizing clinical judgment and looking at the overall patient |
12:30 | Special Event: Financial Planning for Women Pharmacists with Melissa Myers |
1:30 |
Panel: Emerging Trends in Pharmacogenomics
|
3:45 | Fireside Chat: Role of Pharmacist in PGX And How to Take the Whole Patient into Account |
5:00 | End of Day 1 |
Tuesday, October 25 | |
10:45 | Panel: Opportunities (and challenges) To Whole Health Care Team Acceptance |
11:30 |
1) Maternal and pediatric: Jena Quinn, PharmD, BCPPS, Owner, Perfecting Peds · Resources for maternal health and pediatrics · How approach to a maternal/ fetal patient · How to approach a pediatric patient · Pharmacogenomics in a Peds patient 2) Re-imbursement from managed care – Yana Vorontsova, Pharmacogenomics Program Leader, Nicklaus Children’s Health System 3) Geriatric – Delon Canterbury, PharmD, BCGP, Chief Executive Officer, GeriatRx, Inc. 4) Identifying A Population and Getting Grants – Corrie Sanders, Medication Safety Clinical Pharmacist, U.S. Department of Veterans Affairs Pacific Islands Healthcare System, President, Hawai’i Pharmacists Association (invited) |
12:30 | End Of Conference |
2:00 | Workshops begin |
Workshops: October 25
Workshops are 2:00 – 4:30 with a 30-minute break at 3:00
How to Effectively Communicate Your SOPs –Bring Your Own SOP’s to Discuss – Abby Roth, Founder/Microbiologist, Pure Microbiology
- Identify key elements for an effective SOP
- Describe common SOP pitfalls and how to avoid them when drafting SOPs
- Incorporate meaningful SOP training into the sterile compounding organization
Controlled Substances: What To Do or Know Before the DEA Arrives – Carlos Aquino, Compliance Consultant, Founder, Pharma Diversion LLC
- Focus on DEA purpose for reviewing your DEA required records for controlled substances
- Review the requirements to have an effect security program to guard against the diversion of controlled substances
- Discuss the DEA “Know Your Customer” policy and their “Due Diligence” requirements of regulations
Who Should Attend
Quality Assurance |
General Counsel |
Quality Control |
Pharmacy Services |
Pharmacy Operations |
Facilities Management |
Owner / President / CEO |
Supervising pharmacist or non-pharmacist manager equivalent |
Compliance |
Facility manager |
Policy and Regulatory Affairs |
Infection control lead |
Legal |
Process improvement |
Industries
503A Pharmacies
503B Pharmacies
Hospital Pharmacies
Track Chairs
Growth and Alternative Revenue Streams
Dr. Jerrica Dodd
Founder/CEO Your Pharmacy Advocate, Executive Editor, PharmaSis Magazine
Compounding
Lou Diorio
Principal, LDT Health Solutions Inc
Cannabis
Joseph Friedman
Medical Cannabis Pharmacology Expert/Advocate, CannaRPh Consultants LLC
Pharmacogenomics
Jamie Wilkey
co-Founder, PGx Accelerators
Speakers
Compounding
Varsha Gaitonde, PharmD, PhD, BCPS, BCSCP
Vice President, Pharmacy Services, QuVa Pharma, Inc.
Session
CE, On Demand: 503B: Guidance on Essential Copies For 503Bs
In-Person: Essentially A Copy - A Challenge for Both 503A's and 503B's
Compounding
Wendy Hagwood
RPh, PIC, Ops Mgr at Triangle Compounding Pharmacy
Session
Round Table Moderator: Animals are people too
Compounding
Peter Koshland
CEO, Koshland Pharm
Session
Poaching and staff retention
Compounding
Rachael Pontikes
Partner, Reed Smith LLP
Session
CE, On-Demand: Inspection Preparation & Response: During
In Person: 503A Regulatory Update
Compounding
Matthew R. Ludowig
Senior General Counsel, Empower Pharmacy
Session
in-person: Essentially A Copy - A Challenge for Both 503A's and 503B's
Compounding
Lee Rosebush
Partner, BakerHostetler
Session
CE, On-Demand: Inspection Preparation & Response: Before
In-Person: 503B Regulatory Update
Compounding
Vicky A. Caldaro
Manager, Quality Operations , Immucor Inc.
Session
In-Person: Preventing Process Deviations in a Fluctuating Workforce
Compounding, Growth and Entrepreneurship
Syed Saleem DPh, MBA
Senior Director, NexGen Pharmaceuticals
Session
CE, On-Demand: 503B: Qualifying Equipment With The Right Validations
In-Person: TBA
General Session, Compounding
Jim Hrncir RPh
Owner, Las Colinas Pharmacy Compounding
Session
Fireside chat: Creating Protocols for Effective Treatment Of Disorders Affecting the Brain
Panel: Future of Compounding – Growth, Consolidation and New Opportunities
Panel: Retention and Hiring; Staff Development & Advancement
Compounding, Cannabis
Karla L Palmer
Director, Hyman Phelps & McNamara P.C.
Session
In-Person: Essentially a Copy, A Challenge for Both 503As and 503Bs
Compounding
Marc Wagner
Counsel, BakerHostetler
Session
Panel: 503B Regulatory Update
Round Table Moderator: 503B Inspections
Growth and Entrepreneurship, Cannabis
Greg McKettrick RPh
Compounding Pharmacist, Director of Business Development, Stanley Specialty Pharmacy
Session
In-Person: Success With Social Media - Increasing Your Customer Base Through Good Advice
Compounding, Workshop
Carlos M. Aquino
Compliance Consultant, Founder, Pharma Diversion LLC
Session
CE, On-demand: Inspection Preparation & Response: DEA
In-Person: Round Table Moderator, DEA Inspections, Workshop - DEA Inspections
Compounding, Workshop
Abby Roth
Owner/Microbiologist Pure Microbiology, LLC
Session
In-Person Workshop: Effectively writing and communicating SOP's
Compounding
Amy Summers PharmD, BCSCP
Consultant, Restore Health Consulting
Session
Moderator: Preventing Process Deviations in A Fluctuating Workforce
Compounding, Growth and Entrepreneurship
Emily L. Hussey
Attorney, Reed Smith LLP.
Session
CE, On-Demand 503A: Creating a Testing Program
In-Person: TBD
Compounding
Pat Stephens
Lead Consultant & Owner, Stephens Consulting
Session
503B Compliance:
Panel: Preventing Process Deviations in A Fluctuating Workforce
Growth and Entrepreneurship, Compounding
Alexander Pytlarz
Pharmacist, President of Operations, Infuserve America
Session
Fireside chat: Retention and Hiring; Staff Development & Advancement
Growth and Alternative Revenue Streams: Round Table on getting involved in Clinical Trials
Compounding
Devin Wallace CPhT CSPT RPhT PRS
Founder, CEO, Wallace Ventures
Session
Round Table moderator: Cited for what?! The push for CGMP like rules and standards in sterile facilities
Round Table: Are you effectively moving technicians into leadership roles
Compounding
Travis Leeah
Vice President Clinical Services and Pharmacist-in-Charge, QuVA Pharma
Session
Round table moderator: State licensing for 503B's
Round table moderator: How to address opioid state fees
Compounding
Jodi Peterson
President/Owner, Precision Compounding Pharmacy
Session
Round Table: Marketing – Traditional and Social Media Campaigns, Efficacy, do’s and don’ts as learned on the fron
Fireside chat: Retention and Hiring; Staff Development & Advancement
Compounding
Robert Hopkins
CFO, Empower Pharm
Session
503A: Relevant USP Chapters: Where to Find All the Information
Cannabis
Joe Jeffries
Pharmacy Director, FarmaceuticalRx
Session
Fireside chat: using data from state prescription drug management program to show reduction on opioid use in lieu of cannabis |
Cannabis
Becky Brown
Doctor of Pharmacy Cannabis Educator & Coach Pharmedwell.com
Session
CE PRESENTER: Cannabis Pharmacology 101
ROUND TABLE MODERATOR: Building your external/auxiliary team
Cannabis
Jason S Nelson
COO, Beleaf Medical
Session
Panel: Discussion on Politics of Cannabis Treatment
Round Table Moderator: Different Q/A thresholds in different state markets
Cannabis
James T. O'Donnell
President, Consultant, Pharma consultant Inc., Associate Professor, Rush Medical College
Session
Round Table: Exploring The Science – ask your questions here
Fireside Chat – Legal Risks To Users
Cannabis
Robert Morris
Pharmacist, Beehive Farmacy
Session
Panel: Discussion on Politics of Cannabis Treatment
Round table: Routes of Administration and Cannabis and Cannabinoids Dosing
Cannabis
Erik Bowen
Owner,Illume Cannabis Wellness
Session
Panel Moderator: Utilizing Cannabis as A Therapy for Chronic Pain
Round Table: Fair Market Value of Pain Creams
Cannabis
Ashley Robins
Ashley Robins, Marketing and Policy Lead, ANJA
Session
Regulatory Update: Hemp – 2018 US Farm Bill – Delta 8 THC,Delat 9 THC, Delta 10 THC
Panel: Discussion on Politics of Cannabis Treatment
Cannabis
Lauren Vrabel
Cannabis Pharmacist, Scientific Advisor, The Cannigma
Session
Round table: Adverse event reporting
Panel: Risks to Patients that Need to Be Considered
Cannabis
Cassandray Gosa PharmD, MPH
Medical Cannabis Pharmacist, Founder, ChirpRX
Session
Panelist: Utilizing Cannabis as A Therapy for Chronic Pain Management
Round Table Moderator: 4th Year Rx Student APPE Clinical Rotation
Cannabis
Chad E. Burks, PharmD MBA MSMIT
VP, PIC, Westmoreland Clinical Services
Session
Panelist: Precision Medicine in Pharmacy: The Future of Clinical Management of Diseases
Round Table Moderator: Marketing – Getting Your Foot in The Door
Pharmacogenomics
Jeri Nichols, MS, PharmD, CGC
GenePharmer, LLC
Session
Panelist: Precision Medicine in Pharmacy: The Future of Clinical Management of Diseases
Panelist: Emerging Trends in Pharmacogenomics
Growth and Entrepreneurship
Melissa Myers, CFP
Wealth Manager-Melissa Myers’ Team Kar-Mel Financial Planners
Session
Panelist: How do you grow without a team?
Round Table: Financial planning for the future
Pharmacogenomics
Jena Quinn, PharmD, BCPPS
Business Owner, Perfecting Peds
Session
Panelist: Why Be Entrepreneurs, Creating Subsidiaries and Alternative Revenue Streams
Round table moderator: Maternal and pediatric
Panel and round table moderator: Marketing
Pharmacogenomics
DeLon Canterbury, PharmD, BCGP
African American COVID-19 Task Force (AACT+) President/CEO of GeriatRx, Inc.
Session
Panel: Lets Talk To The Consultants To Consult About Being A Consultant
Panel: Opportunities (and challenges) To Whole Health Care Team Acceptance
Round Table: Specialized Populations - Geriatric
Growth and Entrepreneurship
Dr. Jerrica Dodd
Pharmacist Coach, Executive Editor PharmaSis Magazine
Session
Are you stuck? Do you want to move forward in your life, become an entrepreneur, create new revenue streams for your business but find yourself unable to make any changes? Join Dr. Jerrica Dodd as she shares pearls and coaches on moving forward and building your dreams.
Panelist: How do you grow without a team?
Cannabis
Dr. Leah Johnson PharmD, RPh
Medical Cannabis Consultant Pharmacist, Alchemist Consulting
Session
Regulatory Update: Hemp – 2018 US Farm Bill – Delta 8 THC, Delta 9 THC, Delta 10 THC
Panel: Utilizing Cannabis as A Therapy for Chronic Pain Management
Panel: Risks to Patients that Need to Be Considered
Round Table: Improving patient relationships with practitioners
Pharmacogenomics
Kevin Lazaruk RPh, BCGP, BCMAS
LTC Consultant, Author
Session
Opportunities (And Challenges) To Whole Healthcare Team Acceptance
Reviewing clinical data Is utilizing clinical judgment and looking at the overall patient
General, Cannabis, Pharmacogenomics
Dr. Thomas Kupiec
CEO, ARL Bio Pharma, Inc and DNA Solutions
Session
Regulatory Update: Hemp – 2018 US Farm Bill – Delta 8 THC, Delta 9 THC, Delta 10 THC
Panel: Emerging Trends in Pharmacogenomics
Precision Medicine and the future management of diseases
FDA Online - October 20
Ian Deveau
Deputy Office Director, FDA
Session
October 20, Virtual presentation and fireside chat
FDA Online - October 20
Gabrielle Cosel
Director, Division of Compounding Policy and Outreach, Office of Compounding Quality and Compliance at FDA
Session
October 20, Virtual presentation and fireside chat
More Speakers To Be Announced